Insider sale
RETINALGENIX TECHNOLOGIES INC.
$352.0K
100K shares
What this filing means
BAYERN STEVEN plans to sell 100K shares of RETINALGENIX TECHNOLOGIES INC. valued at approximately $352.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/19/2025ACC: 0001641172-25-011496
100K
Shares to sell
$352.0K
Approx. market value
4.21M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
EXERCISE WARRANT
CHECK
9/1/2018
4.21MTotal acquired4.21M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2018 | EXERCISE WARRANT CHECK | 4.21M | — |
| Total | 4.21M | ||
Planned & Completed Dispositions1
OTCQBPlanned
Units to sell
100K
Market value
$352.0K
5/12/2025
Total
Units
100K
Value
$352.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/12/2025 | 100K | $352.0K | OTCQB | Planned |
| Total | 100K | $352.0K | ||